Galeterone Study Sheds Light on Promising Next-Gen Therapies for Advanced Prostate Cancer

Galeterone Study Sheds Light on Promising Next-Gen Therapies for Advanced Prostate Cancer
A new study shows how galeterone is metabolized in the body, suggesting that it shares similarities with other steroidal anti-androgen drugs used to treat advanced prostate cancer. The finding could lay the foundation for development of next-generation drugs that offer better treatment options for the disease. The study titled, “Steroidogenic Metabolism of Galeterone Reveals a Diversity of

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.